The Washington Post Defines Common Cannabis Usage and Terms
As part of their Well+Being section, The Washington Post released a guide to cannabis terms this month to highlight the key differences between them.
On May 13, 2023, The Washington Post published an article in the Well+Being column titled “How Are Marijuana, Cannabis and Hemp Different? A Guide to Weed Terms,” resulting in over 549 comments in the now-closed comment section (1). According to its website, Well+Being from The Washington Post covers healthy living, nutrition, fitness, mental health, relationships, chronic illness, and disability (1).
The article reportedly interviewed several experts and defined 19 terms including “cannabis,” “marijuana,” and “hemp,” but also terms such as “joint,” “terpenes” and “tincture.” References cited included Shanna Babalonis, the director of the UK Cannabis Center at the University of Kentucky; Monique McHenry, director of the Medical Cannabis Center for Research and Education at the University of Vermont; Sean Myles, an associate professor in agriculture at Dalhousie University; and the World Health Organization.
Also listed in the article is a “What to Know About Marijuana” section with over a dozen suggested articles including “Does Weed Help with Anxiety or Cause It? Here’s What Experts Say,” “What to Do If Your Pet Eats Your Weed,” and “How to Be a Good Weed Tourist.”
Reference
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
